Skip to main content
Year archive

Hua Medicine — 2020 filings

All 38 regulatory filings released by Hua Medicine (2552) in 2020, sourced directly from the official regulator.

38 Filings
2020 Period
2020 filings (38)
Filing Released Lang
BUSINESS UPDATE ON COMPLETION OF DAWN (HMM0302), DORZAGLIATIN'S PHASE III METFORMIN COMBINATION TRIAL ANNOUNCEMENT OF POTENTIAL INSIDE INFORMATION
Capital/Financing Update
2020-12-18 English
BUSINESS UPDATE ON COMPLETION OF DAWN (HMM0302), DORZAGLIATIN'S PHASE III METFORMIN COMBINATION TRIAL ANNOUNCEMENT OF POTENTIAL INSIDE INFORMATION
Capital/Financing Update
2020-12-17 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-12-03 English
VOLUNTARY ANNOUNCEMENT - UPDATE REGARDING RECENT BUSINESS DEVELOPMENTS HUA MEDICINE ANNOUNCES ADDITIONAL DATA IN BETA-CELL FUNCTION
Regulatory Filings
2020-11-26 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2020-11-04 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2020-10-07 English
INTERIM REPORT 2020
Regulatory Filings
2020-09-29 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2020-09-04 English
GRANT OF SHARE OPTIONS
Capital/Financing Update
2020-08-19 English
BUSINESS UPDATE ON COMMERCIALIZATION AGREEMENT AND STRATEGIC PARTNERSHIP FOR INVESTIGATIONAL FIRST-IN-CLASS NOVEL DIABETES TREATMENT DORZAGLIATIN WITH BAYER IN CHINA ANNOUNCEMENT OF POTENTIAL INSIDE I
Capital/Financing Update
2020-08-17 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2020
Interim / Quarterly Report
2020-08-17 English
Date of Board Meeting
Report Publication Announcement
2020-08-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-08-05 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change
2020-07-21 English
Monthly Return of Equity Issuer on Movements in Securities
Capital/Financing Update
2020-07-06 English
BUSINESS UPDATE ON COMPLETION OF HMM0302, DORZAGLIATIN'S PHASE III METFORMIN COMBINATION TRIAL ANNOUNCEMENT OF POTENTIAL INSIDE INFORMATION
Regulatory Filings
2020-07-01 English
List of Directors and their Role and Function
Board/Management Information
2020-06-26 English
CHANGE OF AUDIT COMMITTEE MEMBER
Board/Management Information
2020-06-26 English
Poll Results of the Annual General Meeting Held on June 25, 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-26 English
BUSINESS UPDATE ON COMPLETION OF SEED (HMM0301)
Regulatory Filings
2020-06-18 English
VOLUNTARY ANNOUNCEMENT - UPDATE REGARDING RECENT BUSINESS DEVELOPMENTS-HUA MEDICINE ANNOUNCES ADDITIONAL DATA IN BETA-CELL FUNCTION
Regulatory Filings
2020-06-15 English
Monthly Return of Equity Issuer on Movements in Securities
Capital/Financing Update
2020-06-03 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2020-05-22 English
(I) PROPOSED RE-ELECTION OF RETIRING DIRECTORS&#x3b; (II) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES&#x3b; (III) PROPOSED RE-APPOINTMENT OF AUDITOR&#x3b; AND (IV) N
AGM Information
2020-05-22 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 25, 2020
AGM Information
2020-05-22 English
Monthly Return of Equity Issuer on Movements in Securities
Capital/Financing Update
2020-05-06 English
VOLUNTARY ANNOUNCEMENT - HUA MEDICINE ANNOUNCES POSITIVE RESULTS OF THE COMBINATION STUDY OF DORZAGLIATIN WITH EMPAGLIFLOZIN (A SGLT-2 INHIBITOR)
Capital/Financing Update
2020-04-27 English
Environment, Social and Governance Report 2019
Environmental & Social Information
2020-04-22 English
Annual Report 2019
Annual Report
2020-04-22 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change
2020-04-07 English
GRANT OF SHARE OPTIONS
Capital/Financing Update
2020-04-06 English
Monthly Return of Equity Issuer on Movements in Securities
Major Shareholding Notification
2020-04-03 English
GRANT OF SHARE OPTIONS
Capital/Financing Update
2020-03-17 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2019
Annual Report
2020-03-16 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2020-03-04 English
Date of Board Meeting
Regulatory Filings
2020-03-02 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2020-02-05 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2020-01-06 English